Legal 500
  • Rankings

    • Jurisdictions

    • Submissions

    • Research+

    • Future Lawyers

  • Firms & Lawyers

    • Service Providers

    • Barristers’ Sets

    • Networks

    • Interview with…

  • In-House

    • In-House Content

    • GC Powerlist

  • Knowledge Centre

    • Data Products

    • Legal Business

    • News & Developments

    • About us

      • Legal 500

      • FAQs

      • Marketing

      • Careers

      • Contact us

  • Comparative Guides

  • Events

  • Legal 500 TV

About us

  • Legal 500

  • FAQs

  • Marketing

  • Careers

  • Contact us

  • Deutschland DE

  • Paris FR

  • Rankings

    • Jurisdictions

    • Submissions

    • Research+

    • Future Lawyers

  • Firms & Lawyers

    • Service Providers

    • Barristers’ Sets

    • Networks

    • Interview with…

  • In-House

    • In-House Content

    • GC Powerlist

  • Knowledge Centre

    • Data Products

    • Legal Business

    • News & Developments

    • About us

      • Legal 500

      • FAQs

      • Marketing

      • Careers

      • Contact us

  • Comparative Guides

  • Events

  • Legal 500 TV

About us

  • Legal 500

  • FAQs

  • Marketing

  • Careers

  • Contact us

  • Deutschland DE

  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Data Protection policies
  • Cookies Policy
  • Contact Us
  • Article

    Canada: Developing A Framework For Pan-Canadian Drug Pricing Negotiations

    Provincial and territorial premiers first announced the Pan-Canadian Pricing Alliance (PCPA), an initiative aimed at facilitating multi-jurisdictional negotiations on prices of brand name drugs, back in the summer of 2010.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    Pharma In Brief - Canada: Health Canada Announces Position On Unapproved Medical Devices

    Health Canada has issued an update to its earlier position, and has announced its current position on certain activities associated with unapproved medical devices in Canada, and the corresponding roles and responsibilities of stakeholders and industry.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    Pharma In Brief - Plain Language Labelling Requirements Take Effect For Drug Products

    The Regulations Amending the Food and Drug Regulations (Labelling, Packaging and Brand Names of Drugs for Human Use) – more commonly known as the "Plain Language Labelling amendments" – came into force on June 13, 2015.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    New Requirements For Foreign Nationals Entering Canada

    Effective August 1, 2015, the electronic travel authorization program will be implemented in Canada.
    CanadaImmigration
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    Managing Uncertainty: Political Risk Insurance

    One of the fundamental principles of finance is that with greater risk comes the possibility of greater returns.
    CanadaInsurance
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    Cadeau de Noël?

    Nous avions parlé dans ce billet des importants changements proposés à la Loi sur les brevets par le projet de loi C-43 ?
    CanadaIntellectual Property
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    IP Monitor - Drug Labels That Canadians Can Understand

    Health Canada introduced the regulatory amendments in July 2014 as part of its Regulatory Transparency and Openness Framework and its commitment to make information more readily available to Canadians.
    CanadaIntellectual Property
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    Le Secret Professionnel Entre Agents De Brevets Et Clients Devient Loi !

    Vous vous rappelez le billet de mon collègue Pierre intitulé « Fameuses nouvelles dans le Budget fédéral ! » ?
    CanadaIntellectual Property
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    L’été IPIC-McGill

    Avec juillet arrivent les vacances, la canicule et ma pelouse qui se meurt de soif ! C’est aussi le moment de l’année où les cours en propriété intellectuelle IPIC-McGill ont lieu.
    CanadaIntellectual Property
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    Bright Future Predicted For Mid-Market M&A

    MergerMarket Group recently published a research report that presents the expectations of 50 industry experts based in the US and Canada on North American mid-market M&A activity.
    GlobalCorporate/Commercial Law
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    Global M&A Appetite: Executives Continue To Be Hungry

    Executives around the world have a strong appetite to pursue acquisitions, the highest in six years, according to Ernst & Young's Global Capital Confidence Barometer (the Report), released at the end of October.
    GlobalCorporate/Commercial Law
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    Global M&A Driven By Record Valuations

    Global M&A continues to rise with over $2.19 trillion recorded in the first half of 2015, according to Dealogic data.
    GlobalCorporate/Commercial Law
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    M&A Activity In The Pharmaceutical Sector Is Driving The Commercialization Of New Drugs

    The global pharmaceutical sector has been rocked by several significant mergers and acquisitions in 2015...
    GlobalCorporate/Commercial Law
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    M&A Trend Summary: H2 2014

    Overall, there were 16,588 reported deals in the second half of 2014 worldwide, worth roughly $3.2 trillion; this surpasses the previous record, in the second half of 2007, of 16,060 transactions, worth roughly $3.7 trillion.
    GlobalCorporate/Commercial Law
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    More And Bigger: Global And North American M&A Market Update

    The 2014 trend of high value deals continues, according to a recently released Mergermarket Monthly M&A Insider report on global M&A activity.
    GlobalCorporate/Commercial Law
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    Webinar – M&A in 2015: Successor Liability Under The FCPA

    Join us on Thursday, February 26, 2015 for a webinar on successor liability under the US Foreign Corrupt Practices Act (FCPA).
    CanadaCorporate/Commercial Law
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    Post-deal Litigation: What It Is And How To Avoid It

    A phenomenon is pervasive in the United States and is becoming much more common in Canada: post-deal litigation.
    CanadaCorporate/Commercial Law
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    Court Declares That Trademarks May Be Displayed In Quebec Solely In A Language Other Than French

    The Quebec Superior Court has decided, in a long-awaited judgment, that businesses in Quebec may continue to display their trademarks on public signs outside their premises solely in a language other than French if no French version of the trademark has been registered
    CanadaIntellectual Property
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    Forum Selection By-laws Come To Canada

    A forum selection by-law can be used by corporations to help ensure that lawsuits regarding the internal affairs of the corporation are limited to a single jurisdiction as chosen by the corporation (usually the jurisdiction of incorporation or of the corporation's headquarters).
    CanadaCorporate/Commercial Law
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    December 2015 Investment Funds Practitioner: Issues And Tips

    Scholarship plans commonly employ a commission structure that dedicates subscribers' initial contributions to paying down an up-front sales commission that is paid to sales representatives.
    CanadaFinance and Banking
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP

Showing 281–300 of 1189 results

PreviousNext